Introduction {#S1}
============

There is mounting evidence that cardiorespiratory fitness is strongly associated with survival in cancer and non-cancer populations ^[@R1]-[@R4]^. Impaired cardiorespiratory fitness may also be associated with the development of malignancy ^[@R5]-[@R7]^. Within the field of exercise physiology, cardiopulmonary exercise testing performed using indirect calorimetry is considered the gold standard for the assessment of maximal oxygen uptake, and may predict who is more likely to survive hematopoietic cell transplantation (HCT) ^[@R8]-[@R10]^. Due to the association of cardiorespiratory fitness with mortality, several investigators have developed exercise programs for cancer patients, with results suggesting a net positive impact of exercise upon health-related quality of life, treatment toxicity, relapse incidence, and overall mortality in several cancer settings ^[@R11]-[@R15]^.

Currently, most exercise recommendations for cancer patients are directed toward survivors, and statements about intensity are general in nature ^[@R16]^. Many of the exercise studies in cancer have been performed in patients with breast cancer, and transplant exercise studies have usually been performed in the post-transplant setting ^[@R17]^. However, peri-transplant exercise interventions have potential to mitigate post-transplant toxicity. Wiskemann et al. ^[@R18]^ demonstrated significant improvements in post-transplant fatigue and physical fitness/functioning as a result of moderate peri-transplant exercise, and also showed that exercise after allogeneic transplant may improve mortality.^[@R19]^ Though a large, recently conducted study of peri-transplant exercise training did not demonstrate an improvement in post-transplant health-related quality of life, this study had a very different design than the above studies and was an intervention of significantly lower intensity. ^[@R20]^

Recent evidence supports the use of higher intensity exercise as an approach for inducing rapid improvements in cardiorespiratory fitness ^[@R21],\ [@R22]^. As a result of the intense treatment utilized in HCT, and the accompanying effects of HCT treatment upon cardiorespiratory fitness, pulmonary function, and skeletal muscle capacity, exercise intensity may be an important factor in this population to mitigate transplant toxicity ^[@R23],\ [@R24]^. Higher intensity exercise approaches have begun to be explored in cancer patients ^[@R25]-[@R27]^. Home-based training utilizing higher-intensity intervals of exercise may offer several advantages, including modifiability to fit the needs of patients, adaptability to the home setting, and requirement of less overall time than traditional approaches to improve fitness ^[@R28]-[@R30]^.

The purpose of this study was to evaluate the feasibility and physiological effects of a home-based interval exercise training (IET) intervention for cancer patients in the pre-hematopoietic stem cell transplant period. We sought to address a key limitation in the field of exercise oncology research, namely that home-based exercise prescriptions are insufficiently personalized and/or lacking the appropriate adaptability and intensity necessary to achieve improvements in fitness and long-term cancer outcomes. We also wished to evaluate the physiological effects from a tailored program that patients could realistically complete in the pre-transplant period. We drew upon data from supervised high-intensity interval training in other populations suggesting that interval-based exercise efficiently improves cardiorespiratory fitness within a period of weeks ^[@R30],\ [@R31]^. We hypothesized that a home-based, interval training intervention, personalized by targeting participant heart rate percentages derived from individual maximal heart rates during exercise testing, could be feasibly performed by cancer patients in the weeks leading up to HCT. This hypothesis was tested in separate cohorts of autologous and allogeneic pre-transplant patients.

Materials and Methods {#S2}
=====================

Participants {#S3}
------------

Participants between the ages of 18-75 years were recruited from among patients preparing to undergo autologous or allogeneic HCT at the University of North Carolina from 07/2013 through 10/2014 ([Table 1](#T1){ref-type="table"}). In order to participate, patients had an upcoming planned autologous or allogeneic transplant with enough time to accommodate a six week exercise intervention. Participants could not have received erythropoiesis-stimulating agents (ESAs) within four weeks prior to enrollment, nor could they have a comorbid illness that would preclude participation in maximal effort exercise testing or regular exercise, as determined by the treating physicians. Of the 98 patients approached for enrollment and meeting eligibility criteria, 49 agreed to participate, signing an approved consent form ([Figure 1](#F1){ref-type="fig"}). Of the 49 that consented, 9 withdrew from the study as a result of a change in treatment plan, disease progression, or lack of interest. The final cohort analyzed was a total of 40 patients (20 autologous and 20 allogeneic transplant recipients). This protocol was approved by the Biomedical Institutional Review Board at the University of North Carolina and all procedures are in accordance with the Helsinki Declaration of 1975. All participants provided written informed consent prior to participation in any study-related activities

Physiological Testing {#S4}
---------------------

Physiological testing occurred before and after the 6-week home-based IET program. All participants underwent baseline maximal cardiopulmonary exercise testing (CPET) with cycle ergometry (VO~2~peak) as previously described ^[@R9]^. Briefly, this graded exercise test was completed on an electronically braked cycle ergometer (Corival 400, Lode, Gronigen, The Netherlands). Participants were fitted with a facemask (NRB1, Hans Rudolph Inc., Kansas City, MO) in order to ensure a secure seal around the nose and mouth. Participants completed a 2 minute warm-up with no resistance, maintaining pedal cadence between 50-70 rpm. The initial stage was set to 25 watts (W) for all participants. Subsequent stages were increased based on the subject's fitness level and leg strength (10-25W), as determined by an exercise physiologist. Workloads were kept consistent for pre- and post-testing. Respiratory gases were monitored continuously and analyzed with open-circuit spirometry using a calibrated metabolic cart (True One 2400, Parvomedics, Provo, UT). Data was averaged over 15-seconds, with the three highest 15-second oxygen consumption values from the final minute identified as VO~2~peak. Heart rate was monitored continuously throughout the duration of the protocol using a polar heart rate strap (Model FT1, Polar, Inc., Lake Success, NY). The VO~2~peak test was conducted to determine cardiorespiratory fitness and to establish participant-specific maximal heart rates (MHR). A 6-minute walk distance (6MWD) was also obtained at baseline using a standardized protocol. Patients walked a 15 meter flat corridor unaccompanied, turning 180° every 15 m in the allotted 6 minute time frame. Patients were allowed to rest if needed, and time remaining was called every 2 minutes. After the 6 minutes, total distance travelled was calculated, and was reported as the 6MWD.

Interval Exercise Training {#S5}
--------------------------

Following baseline exercise testing, participants were educated about how to participate in IET at home using target heart rates established from the VO~2~peak test. An exercise physiologist discussed which mode might be most advantageous for that patient to achieve target heart rates. Modes performed by the participants included variations in walking, running, and/or cycling; participants were encouraged to maintain the same mode throughout the duration of the study. All participants were provided with heart rate monitors (FTI, Polar Inc.) to facilitate training. Monitors were set according to calculated training zones, providing a beep when a patient achieved the HR zone. For weeks one and two of the 6-week home-based intervention, participants were asked to perform three, 30 minute walking sessions with one, 3-minute higher intensity interval (60-70% MHR) per session. For the subsequent 4 weeks, participants were asked to perform a greater volume and intensity of IET training consisting of five, 3-minute higher intensity intervals (65-95% MHR) during each 30 minute session, 3 times per week. Participants were instructed to reduce intensity or rest between intervals ([Figure 2](#F2){ref-type="fig"}). Because participants were allowed to train at an MHR as low as 65%, this was not strictly a high intensity training program by American College of Sports Medicine (ACSM) standards,^[@R32]^ though most participants did achieve a high percentage of MHR (see results). All training sessions were recorded on a paper log, including maximum heart rate achieved per session and date of completion. Additionally, all participants were provided with accelerometers (FitBit Flex, Fitbit, Inc., San Francisco, CA) and were instructed to wear these throughout the duration of the home-based exercise intervention, through hospitalization for transplant, and for four weeks post discharge. Participants were also instructed to record completion of each session and maximum heart rate achieved per session on an interval training log. Weekly calls were provided by the study team in order to provide motivation, answer questions, and to address potential issues such as a declining health status, equipment dysfunction, or intervention related adverse events. Participants were also encouraged to contact the study team at any time to discuss any issues encountered during the IET program. After the completion of the IET program and prior to transplantation, participants underwent the same fitness assessments performed at baseline which included a maximal cardiopulmonary exercise test (VO~2~peak) and 6MWD.

Statistical Analysis {#S6}
--------------------

Descriptive statistics (including medians, interquartile ranges (IQR), and percentages) were calculated for both cohorts separately. Feasibility of the program was evaluated by adherence data, including number of weeks completed and number of IET sessions initiated and completed, respectively. Physiological effects (e.g. VO~2~peak, 6MWD) were evaluated on the change scores from pre to post-training using Wilcoxon Signed Rank tests, with a p-value of less 0.05 considered significant. Sample size for this study was based on previous data from the authors ^[@R30]^, anticipating a 2 ml/kg\*min change in VO~2~peak with a standard deviation of 2.5 ml/kg\*min. A total of 20 patients, in this single arm, non-randomized intervention, were needed to achieve 92% power. Due to the novelty of the intervention and the ability to evaluate autologous and allogeneic groups separately, 20 patients per group were recruited. Analyses were conducted using SAS Statistical Software (version 9.3, Cary, NC).

Results {#S7}
=======

Of the 40 total patients enrolled, disease classification consisted of acute myeloid leukemia (n=6 allo); acute lymphoblastic leukemia (n=2 allo); multiple myeloma (n=13 auto; n=1 allo), chronic myeloid leukemia (n=1 auto; n=2 allo); myelodysplastic syndrome (n=4 allo); non hodgkin lymphoma (n=3 auto; n=1 allo); myelofibrosis (n=1 allo); aplastic anemia (n=1 allo) and other (n=3 auto; n=1 allo).

Adherence and Efficacy {#S8}
----------------------

### Autologous Transplant Cohort {#S9}

Among pre- autologous transplant recipients, most patients (n=16) had at least 6 weeks before their transplant, with the remaining having 3-5 weeks available prior to transplant. For the 20 patients in this group, 6 (30%) participated in more than 75% of the training sessions. The entire group completed a median of 39% of the IET sessions. Among all autologous recipients, initiation of a median of 7 total IET sessions (IQR 3-15) were recorded during the intervention period. The median duration of each IET session was 30 minutes. The highest recorded maximal heart rate percentage (MHR, from the Karvonen Prediction Equation) achieved at any time during IET sessions was a median of 94.6% MHR. Recorded daily activity of participants using accelerometry was a median of 5546 steps per week (IQR 3929-7469) throughout the intervention period.

Evaluation of the physiological change from pre- to post-intervention for VO~2~peak demonstrated a median increase of 1.1 ml/kg\*min (p=0.121), and a median increase of 30.1m for the 6MWD (p=0.19) ([Table 2](#T2){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}).

### Allogeneic Transplant Cohort {#S10}

Among pre-allogeneic transplant recipients, all patients had 6 weeks available prior to transplant. Of the 18 total sessions available, 7 (35%) completed more than 75% of the IET sessions; the entire group completed a median of 47% of the IET sessions. Allogeneic recipients recorded initiation of a median of 11 total IET sessions (IQR 5-16). The median duration of each IET session was 30 minutes. The highest recorded maximal heart rate (MHR) percentage achieved at any time during IET sessions was a median of 91.3% MHR for the allogeneic cohort. Allogeneic recipients walked a median of 5178 steps per week (IQR 4186-6554) throughout the intervention period.

Analysis of VO~2~peak from pre- to post-intervention demonstrated a significant median improvement of 3.7 ml/kg\*min (p=0.005) and a significant median improvement in 6MWD of 34m (p=0.006) in this cohort.

Safety and Adverse Events {#S11}
-------------------------

There were no study-related adverse events identified in either the autologous or allogeneic cohort that were directly related to the exercise testing or exercise intervention. Adverse events could be reported by the study team, nursing staff, treating clinicians, or the patients themselves.

Discussion {#S12}
==========

This is one of the first reports of a home-based, personalized, interval exercise training program in cancer patients preparing to undergo hematopoietic cell transplantation. Our data show that the personalized IET program, based on maximal heart rate, could be performed at home and appeared to be safe. The IET intervention also resulted in improvements in cardiorespiratory fitness in patients, most notably in the pre-allogeneic transplant group. These findings are of clinical relevance, as pre-transplant cardiorespiratory fitness has been demonstrated to predict post-transplant survival ^[@R9]^.

Interestingly, the present results demonstrate that VO~2~peak values significantly improved after the exercise intervention in the pre-allogeneic transplant population, but cardiorespiratory fitness changes were not significant in the pre-autologous transplant population. Rates of adherence, and achievement of target heart rates, did not appear to differ significantly between these two cohorts, and despite the non-significance, the pre-autologous group did demonstrate a small median improvement in VO~2~peak. However, the differences between groups may be partially explained by a number of the autologous transplant patients undergoing stem cell mobilization and collection during or overlapping with the IET program. This observation is important for a few reasons. First, our data show that IET appears to be feasible and safe around the time of mobilization and collection. Second, it is possible that stem cell mobilization has a detrimental impact upon cardiorespiratory fitness as measured by CPET. On the other hand, the autologous transplant cohort appeared to experience rapid collection and robust stem cell yields. In this cohort, 100% underwent successful stem cell mobilization on the first attempt, using either etoposide chemo-mobilization or G-CSF mobilization per institutional protocol. 74% of patients collected adequate cells within 1 day of collection, with all other patients, except for 1 collecting within 2 days (the exception was a patient with a higher collection target to support 3 auto transplants for germ cell tumor, who required a third day). The median total stem cell dose collected for the autologous cohort was 6.2 × 10^6^/kg CD34+ cells, with 5 patients collecting more than 10 × 10^6^/kg and 1 patient collecting 32.4 × 10 ^6^/kg CD34+ cells. Pre-clinical and clinical data suggests that exercise may enhance progenitor cell mobilization, lending some biological plausibility to these findings and suggesting further study in this area ^[@R33]-[@R35]^.

In contrast to the autologous cohort, the pre-allogeneic transplant cohort experienced a significant improvement in VO~2~peak measurements. The median improvement of 3.7 ml/kg\*min represents a significant benefit in cardiorespiratory fitness for a short term intervention. It is possible that the interval-based nature of the intervention might help to explain this observation, as supervised interval training programs have been associated with efficient improvements in cardiorespiratory fitness in short periods of time in other, non-cancer populations ^[@R30],\ [@R36],\ [@R37]^. A randomized study would be required to demonstrate that the IET protocol was ultimately responsible for the fitness improvements that were seen in our pre-allogeneic transplant population, and to determine whether cardiorespiratory fitness improvements translate into improved post-transplant outcomes. Of note, it was apparent that responses and non-responses in the allogeneic transplant cohort could not be attributed solely to the degree of participation in the interval exercise training sessions. It is possible that factors related to underlying individual physiology or disease- or treatment-related effects may have contributed to differential responses among participants with similar levels of participation (or non-participation) in the intervention. Larger studies will be needed to adequately account for other potential predictors of response to this exercise intervention.

We acknowledge several limitations to this pilot study, and opportunities for improvement in follow-up work that will test the hypothesis that pre-transplant interval exercise training improves pre-transplant fitness and potentially post-transplant outcomes and survival. First, this was a non-randomized study with a relatively small sample, with findings that need validation in larger, randomized cohorts. Second, though we allowed a relatively wide range of targeted % MHR for the interval training, supported by the observation that exercise intensity ranges may be defined differently in cancer patients undergoing transplant than in healthy individuals ^[@R38]^. Third, the recruitment rate of eligible patients was not as high as observed in previous pre-transplant exercise studies. It is possible that the intensity of our intervention may have dissuaded potential participants, though other reversible workflow limitations in our clinical environment may have also influenced recruitment, which we plan to address in future studies. For example, improving the logistics of testing sessions around convenient times for patients, many of whom were traveling significant distances to our cancer center, would have facilitated better recruitment and will be addressed in subsequent work. Fourth, while feasible and safe, participation in the weekly interval sessions was lower than desired. However, participants reported maximal heart rates during their interval training that that were within the prescribed intensity range for the intervention. Additionally, because of the frequency and complexity of the home-based intervention, adherence rates may have been underestimated, as it was challenging for participants to remember to reliably record each completed session using paper diaries. Regardless, the observed improvements in cardiorespiratory fitness in the allogeneic cohort suggest that a low "dose" of interval training may be sufficient to achieve improvement in VO~2~peak. Further improvements to the study procedures to increase and reliably ascertain adherence to the home-based intervention may provide more confidence around the dose effect estimates of the intervention, and may potentially lead to even greater improvements in cardiorespiratory fitness.

Several strategies are available to improve motivation and adherence to this intervention in future work. For example, the rapid development and improvement of wearable technology offers the opportunity to further facilitate the uptake of home-based, personalized exercise prescriptions in transplant and non-transplant populations ^[@R39]^. Several commercially-available wearable devices now provide continuous heart rate tracking capabilities without the need for additional equipment, as was required in our protocol, and enable users to customize exercise bouts and heart rate targets. Importantly, the data tracking capabilities of these devices have significant potential to improve estimates of adherence, and potentially to eliminate the need for participants to manually log each completed IET session in a separate exercise diary. We anticipate that these capabilities may facilitate better intervention adherence in future personalized, home-based exercise prescription protocols.

Home-based, personalized intensive exercise programs have the potential to improve cardiorespiratory fitness in patients preparing to undergo hematopoietic cell transplantation. These programs may be applicable in many settings in which rapid improvement in physiological reserve is a key goal, including the pre-transplant and pre-surgical settings, but also among cancer survivors in general and potentially in the setting of certain types of chemotherapy. Just as there is a national movement towards the application of precision medicine within cancer treatment, the time is also right for the personalized application of exercise programming to improve long-term cancer outcomes.
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![VO2peak (a) and 6MWD (b) changes on an individual participant basis. Red vertical lines represent participants from the autologous transplant cohort, and black vertical lines represent participants from the allogeneic transplant cohort.](nihms-756223-f0003){#F3}

###### 

Patient characteristics at baseline testing. Values are presented as median \[IQR\].

  ---------------------------------------------------------------------------------------------------------
                      Gender     Age (yrs)         Height (cm)          Weight (kg)       Body Mass\
                                                                                          Index (kg/m^2^)
  ------------------- ---------- ----------------- -------------------- ----------------- -----------------
  Autologous (n=20)   14 Male\   60.5\             172.8\               85.0\             28.6\
                      6 Female   \[54.5 - 68.0\]   \[165.5 - 177.25\]   \[73.4 - 97.8\]   \[26.5 - 31.0\]

  Allogeneic (n=20)   12 Male\   52.5\             171.6\               75.4\             27.0\
                      8 Female   \[45.0 - 63.0\]   \[162.6 - 180.0\]    \[68.7 - 97.9\]   \[23.6 - 31.2\]
  ---------------------------------------------------------------------------------------------------------

###### 

Adherence and efficacy data for autologous and allogeneic patients. Values are reported as medians.

  --------------------------------------------------------------------------------------------------------------
                            Autologous Cohort   Allogeneic Cohort                                  
  ------------------------- ------------------- ------------------- ---------- ----------- ------- -------------
  VO~2peak~ (ml/kg\*min)    16.1                +1.1                *0.12*     18.1        +3.7    ***0.005***

                                                                                                   

  VO~2peak~ (L/min)         1.23                +0.15               *0.09*     1.33        +0.31   ***0.004***

                                                                                                   

  6MWD (m)                  525                 +30                 *0.19*     495         +34     ***0.006***

                                                                                                   

  RER (pre-post)            1.15-1.19                                          1.23-1.27           

                                                                                                   

  Number of weeks\          4.0                                     5.0                            
  participated                                                                                     

                                                                                                   

  Number of IET sessions\   7.0                                     11.0                           
  participated                                                                                     

                                                                                                   

  Median duration of IET\   30                                      30                             
  sessions (minutes)                                                                               

                                                                                                   

  Maximum HR achieved\      159, 91%                                161, 89%                       
  (bpm, % MHR)                                                                                     

                                                                                                   

  Daily Steps               5547                                    5178                           
  --------------------------------------------------------------------------------------------------------------
